HIV Diagnostics Market is Gaining Rapid Traction with Roche Diagnostics receiving the U.S. FDA approval for its cobas HIV-1/HIV-2 Qualitative Test on the fully automated cobas 6800/8800 Systems in the U.S.
HIV diagnostics are not as simple to acquire as they may appear to be, and it's important that you get the correct tests for your particular condition. One shouldn't be embarrassed or feel ashamed about getting tested for the disease; after all, there are a lot of people who are living with HIV or AIDS and are leading happy lives. The reason you're being tested is simply so you can get the proper medical help you need, which can help you combat this dangerous disease. Growing prevalence of HIV/AIDS is expected to drive growth of the global HIV diagnostics market . According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), in 2019, 38 million people were living with HIV across the globe, of which 36.2 million were adults and 1.8 million were children aged 15 years and below. According to the same source, around 1.7 million people across the globe acquired HIV in 2019. Such increasing prevalence has led to high demand for advanced HIV diagnostics devices and te...